Mapping of melanoma modifier loci in RET transgenic mice

T. A. Dragani, B. Peissel, N. Zanesi, A. Aloisi, Y. Dai, M. Kato, H. Suzuki, I. Nakashima

Research output: Contribution to journalArticlepeer-review


Transgenic mice carrying the RET oncogene under the control of the metallothionein promoter exhibit severe pigmentation of the whole skin and melanocytic tumors. The genetic background influences melanoma development in RET mice; founder mice crossed with BALB/c mice show decreased incidence and increased latency of melanocytic tumors, whereas progeny of C57BL/6 mice show the opposite effect. Using partially congenic RET mice on a C57BL/6 genetic background (N3/RET mice), we studied genetic linkage in (N3/RETxBALB/c)xN3/RET backcross mice. We mapped three melanoma modifier loci, on chromosome 1 (Melm1 and Melm2) and chromosome 11 (Melm3), that are linked with early melanoma incidence and latency. Mapping of Melm loci and of five additional regions on chromosomes 6, 8, 9, 12, and 13 indicated allelic imbalance in N3/RET mice, with a significant excess of BALB/c alleles, suggesting the presence of additional putative melanoma modifier loci on these chromosomes.

Original languageEnglish
Pages (from-to)1142-1147
Number of pages6
JournalJapanese Journal of Cancer Research
Issue number11
Publication statusPublished - 2000


  • Genetic linkage
  • Melanoma
  • RET
  • Transgenic mice

ASJC Scopus subject areas

  • Cancer Research
  • Oncology


Dive into the research topics of 'Mapping of melanoma modifier loci in RET transgenic mice'. Together they form a unique fingerprint.

Cite this